Regor Therapeutics Company
Regor Therapeutics is a clinical-stage company dedicated to the discovery and development of innovative and clinically differentiated medicines by leveraging the proprietary CARD (Computer Accelerated Rational Discovery) Platform, seamlessly integrating structural biology, computational chemistry, therapeutic biology, medicinal chemistry, and clinical development. Regor has assembled a world-class scientific team and demonstrated high efficiency in producing best- and first-in-class molecules.
Industry:
Drug Discovery & Molecular Sim
Super Industry:
Quantum Medicine
Funding Total Value:
140000000
Last Funding Total Usd:
50000000
Last Funding Total Currency:
USD
Last Funding Total Value:
50000000
Founders:
Min Zhong,Wenge Zhong,Xiaotian Zhu,Xiayang Qiu
Sub-Industry:
PharmTech
Investors:
Eli Lilly, Lilly Asia Ventures, Vertex Ventures China, Loyal Valley Capital, TF Capital
Ipo Status:
private
City:
Shanghai
Region:
Shanghai
Country:
China